These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32270498)

  • 1. Limited transmissibility of coronavirus (SARS-1, MERS, and SARS-2) in certain regions of Africa.
    Ahmed AE
    J Med Virol; 2020 Oct; 92(10):1753-1754. PubMed ID: 32270498
    [No Abstract]   [Full Text] [Related]  

  • 2. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
    Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
    J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topological Analysis for Sequence Variability: Case Study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countries in comparison with SARS-CoV-1 and MERS-CoV.
    Sarkar JP; Saha I; Seal A; Maity D; Maulik U
    Infect Genet Evol; 2021 Mar; 88():104708. PubMed ID: 33421654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses.
    Abdelrahman Z; Li M; Wang X
    Front Immunol; 2020; 11():552909. PubMed ID: 33013925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.
    Wu Z; Harrich D; Li Z; Hu D; Li D
    Rev Med Virol; 2021 Mar; 31(2):e2171. PubMed ID: 33350025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.
    Halaji M; Farahani A; Ranjbar R; Heiat M; Dehkordi FS
    Infez Med; 2020 Jun; 28(suppl 1):6-17. PubMed ID: 32532933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three Emerging Coronaviruses in Two Decades.
    Guarner J
    Am J Clin Pathol; 2020 Mar; 153(4):420-421. PubMed ID: 32053148
    [No Abstract]   [Full Text] [Related]  

  • 8. Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?
    Elrashdy F; Redwan EM; Uversky VN
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32933047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction - Emerging Pathogens and the COVID-19 Pandemic.
    McFee RB
    Dis Mon; 2020 Sep; 66(9):101065. PubMed ID: 32758362
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of the quality of systematic reviews on COVID-19: A comparative study of previous coronavirus outbreaks.
    Yu Y; Shi Q; Zheng P; Gao L; Li H; Tao P; Gu B; Wang D; Chen H
    J Med Virol; 2020 Jul; 92(7):883-890. PubMed ID: 32301508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of infective dose, routes of transmission and outcome of COVID-19 caused by the SARS-COV-2: comparison with other respiratory viruses.
    Karimzadeh S; Bhopal R; Nguyen Tien H
    Epidemiol Infect; 2021 Apr; 149():e96. PubMed ID: 33849679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV.
    Singh A; Singh RS; Sarma P; Batra G; Joshi R; Kaur H; Sharma AR; Prakash A; Medhi B
    Virol Sin; 2020 Jun; 35(3):290-304. PubMed ID: 32607866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.
    Li YC; Bai WZ; Hashikawa T
    J Med Virol; 2020 Jun; 92(6):552-555. PubMed ID: 32104915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS and MERS: recent insights into emerging coronaviruses.
    de Wit E; van Doremalen N; Falzarano D; Munster VJ
    Nat Rev Microbiol; 2016 Aug; 14(8):523-34. PubMed ID: 27344959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures.
    Wang Y; Wang Y; Chen Y; Qin Q
    J Med Virol; 2020 Jun; 92(6):568-576. PubMed ID: 32134116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Acute Respiratory Syndrome Coronavirus (SARS, SARS CoV).
    McFee RB
    Dis Mon; 2020 Sep; 66(9):101062. PubMed ID: 32800504
    [No Abstract]   [Full Text] [Related]  

  • 17. SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review.
    Nascimento Junior JAC; Santos AM; Quintans-Júnior LJ; Walker CIB; Borges LP; Serafini MR
    Expert Opin Ther Pat; 2020 Aug; 30(8):567-579. PubMed ID: 32429703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Super-spreading events and contribution to transmission of MERS, SARS, and SARS-CoV-2 (COVID-19).
    Al-Tawfiq JA; Rodriguez-Morales AJ
    J Hosp Infect; 2020 Jun; 105(2):111-112. PubMed ID: 32277963
    [No Abstract]   [Full Text] [Related]  

  • 19. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option.
    Yao TT; Qian JD; Zhu WY; Wang Y; Wang GQ
    J Med Virol; 2020 Jun; 92(6):556-563. PubMed ID: 32104907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lethal internal face of the coronaviruses: Kidney tropism of the SARS, MERS, and COVID19 viruses.
    Motavalli R; Abdelbasset WK; Rahman HS; Achmad MH; Sergeevna NK; Zekiy AO; Adili A; Khiavi FM; Marofi F; Yousefi M; Ghoreishizadeh S; Shomali N; Etemadi J; Jarahian M
    IUBMB Life; 2021 Aug; 73(8):1005-1015. PubMed ID: 34118117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.